Cerebral Microbleeds in Advanced Dementia: Clinical and Pathological Correlates

Am J Alzheimers Dis Other Demen. 2018 Sep;33(6):362-372. doi: 10.1177/1533317518770783. Epub 2018 May 7.

Abstract

Objective: We conducted a longitudinal study to explore the clinical and pathological correlates of cerebral microbleeds (CMBs) in institutionalized patients with dementia.

Methods: Clinical and magnetic resonance imaging (MRI) data were extracted from 182 nursing home patients (mean age [standard deviation]: 81.3 [6.9], 78.0% female, and 83.4% moderate to severe dementia), which were divided according to the CMBs number and location. One-year follow-up data were obtained from 153 patients, and postmortem pathological diagnosis was available in 40 patients.

Results: Cerebral microbleeds were observed in 42.9% of patients and were associated with MRI ischemic lesions ( P < .0005). In the adjusted analysis, lobar CMB predicted worsening of parkinsonism (standardized β: 0.43) and gait (standardized β: 0.24). A pathological diagnosis of Alzheimer's disease was less frequent in the brains of patients with lobar and deep CMB (33.3% vs 85.3%; P < .05).

Conclusion: Cerebral microbleeds were linked to cerebrovascular disease and predicted motor deterioration in institutionalized people with advanced dementia.

Keywords: Alzheimer’s disease; amyloid angiopathy; cerebral microbleeds; cerebrovascular disease; dementia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Alzheimer Disease / complications
  • Brain / diagnostic imaging
  • Cerebral Amyloid Angiopathy
  • Cerebral Hemorrhage / diagnostic imaging*
  • Cerebral Hemorrhage / etiology
  • Dementia / complications
  • Dementia / diagnostic imaging*
  • Female
  • Humans
  • Longitudinal Studies
  • Magnetic Resonance Imaging*
  • Male
  • Severity of Illness Index